06185.HK
CanSino Biologics, Inc.
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
HKD 25.78
−0.46%Margins
Gross margin
72.0%
EBITDA margin
3.5%
EBIT margin
-4.1%
Net margin
2.4%
FCF margin
-5.1%
0.6%
Return on equity
0.4%
Return on assets
-0.9%
Return on invested capital
0.18x
Asset turnover
HKD 112.8M
Cash from operations
HKD 8.45
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Sep 1, 2026